Alan J Gelenberg

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
    A J Gelenberg
    Arizona Health Sciences Center, Department of Psychiatry, 1501 N Campbell, PO Box 245002, Tucson, AZ 85724 5002
    JAMA 283:3082-8. 2000
  2. ncbi The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
    Alan J Gelenberg
    University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    J Clin Psychiatry 65:1114-9. 2004
  3. ncbi Honoring our evidence base
    Alan J Gelenberg
    Department of Psychiatry, University of Arizona Health Sciences Center, Tucson 85724, USA
    J Clin Psychiatry 65:750-1. 2004
  4. ncbi Sexual side effects of antidepressant drugs
    A J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, 1501 North Campbell Avenue, PO Box 245002, Tucson, AZ 85724 5002, USA
    Curr Psychiatry Rep 2:223-7. 2000
  5. ncbi How fast are antidepressants?
    A J Gelenberg
    Department of Psychiatry, University of Arizona Health Science Center, Tucson 85724 5002, USA
    J Clin Psychiatry 61:712-21. 2000
  6. ncbi Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
  7. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
  8. ncbi Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
  9. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
  10. ncbi Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131 5288, USA
    JAMA 289:56-64. 2003

Detail Information

Publications38

  1. ncbi Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
    A J Gelenberg
    Arizona Health Sciences Center, Department of Psychiatry, 1501 N Campbell, PO Box 245002, Tucson, AZ 85724 5002
    JAMA 283:3082-8. 2000
    ....
  2. ncbi The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
    Alan J Gelenberg
    University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    J Clin Psychiatry 65:1114-9. 2004
    ..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...
  3. ncbi Honoring our evidence base
    Alan J Gelenberg
    Department of Psychiatry, University of Arizona Health Sciences Center, Tucson 85724, USA
    J Clin Psychiatry 65:750-1. 2004
  4. ncbi Sexual side effects of antidepressant drugs
    A J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, 1501 North Campbell Avenue, PO Box 245002, Tucson, AZ 85724 5002, USA
    Curr Psychiatry Rep 2:223-7. 2000
    ..We pay particular attention to sildenafil, on which there are impressive data and ongoing controlled studies...
  5. ncbi How fast are antidepressants?
    A J Gelenberg
    Department of Psychiatry, University of Arizona Health Science Center, Tucson 85724 5002, USA
    J Clin Psychiatry 61:712-21. 2000
    ..For years, investigators have tried to determine the speed of onset of antidepressant drugs. Claims that particular drugs may produce a faster response in patients than other agents have been made, but such claims have never been confirmed...
  6. ncbi Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
    ..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
  7. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
    ..These results and the consistency of similar results over time point to the dire need for patient and provider education regarding the signs and symptoms of depression and its treatment...
  8. ncbi Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
    ..This randomized, placebo-controlled study of the efficacy and safety of nefazodone in preventing recurrence was conducted for patients with chronic MDD...
  9. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
    ..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
  10. ncbi Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131 5288, USA
    JAMA 289:56-64. 2003
    ..Sexual dysfunction is a common adverse effect of antidepressants that frequently results in treatment noncompliance...
  11. ncbi Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
    ..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
  12. ncbi REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Psychopharmacol Bull 41:5-33. 2008
    ....
  13. ncbi Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination
    John Zajecka
    Department of Psychiatry, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 955, Chicago, IL 60612, USA
    J Clin Psychiatry 63:709-16. 2002
    ..This study compares the effects of antidepressant medication, psychotherapy, and combined treatment on sexual interest/satisfaction and function in patients with chronic major depression...
  14. ncbi The state of knowledge of chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, AZ, USA
    J Clin Psychiatry 67:179-84. 2006
  15. ncbi Report by the ACNP Task Force on response and remission in major depressive disorder
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 31:1841-53. 2006
    ..Research to evaluate these recommendations empirically is needed...
  16. doi A review of the current guidelines for depression treatment
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e15. 2010
    ..Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research...
  17. doi Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice
    Alan J Gelenberg
    Healthcare Technology Systems, Inc, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, USA
    J Clin Psychiatry 71:e01. 2010
    ..Assessment tools are available in many languages. Treatment algorithms can rationalize decision making, and collaborative care can speed and enhance treatment results...
  18. ncbi Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes
    Monique M Williams
    Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Diabetes Care 30:801-6. 2007
    ..A secondary analysis was performed to assess this effect in younger and older subsets of patients...
  19. ncbi Matching the bipolar patient and the mood stabilizer
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, Arizona 85724 5002, USA
    Ann Clin Psychiatry 15:203-16. 2003
    ..Randomized, controlled studies in bipolar populations are needed to further characterize optimal matching of patient and medication...
  20. ncbi Health outcomes for people with serious mental illness: a case study
    Terry A Badger
    College of Nursing, University of Arizona, Tucson, USA
    Perspect Psychiatr Care 39:23-32. 2003
    ..To describe outcomes of clients with serious mental illnesses who used regional public mental health services; and what the public mental health system did well or needed to change to better satisfy clients' needs...
  21. ncbi Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients
    Pedro L Delgado
    Department of Psychiatry, Case Western Researve University School of Medicine, Cleveland, OH 44106 5080, USA
    Int J Neuropsychopharmacol 5:63-6. 2002
    ..Mood response to tryptophan or catecholamine depletion is dependent on the pharmacological properties of the antidepressant being taken during depletion...
  22. doi Performance improvement CME: improving outcomes in depression
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e19. 2010
    ..This PI CME focuses on improving the detection and initial treatment of depression, enhancing patients' treatment response, and preventing relapse and recurrence...
  23. ncbi Smoking cessation in patients with psychiatric disorders
    Alan J Gelenberg
    Department of Psychiatry, University of Arizona, Tucson, USA
    J Clin Psychiatry 68:1404-10. 2007
  24. ncbi Assessing and treating depression in primary care medicine
    Alan J Gelenberg
    Department of Psychiatry, University of Arizona, Tucson
    Am J Med 120:105-8. 2007
    ..A variety of pharmacologic and psychosocial treatments are available for treating depression. Most patients who are well treated can be relieved of symptoms and return to full function...
  25. doi Optimizing depression treatment to increase the likelihood of remission
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e22. 2010
    ....
  26. ncbi Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O Hara St, Pittsburgh, PA 15213, USA
    Arch Gen Psychiatry 59:233-9. 2002
    ..Although various strategies have been proposed to treat antidepressant nonresponders, little controlled research has been published that examines prospectively the use of switching to an alternate antidepressant...
  27. ncbi Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131 5286, USA
    Urology 60:58-66. 2002
    ..Given the complex interrelations among ED, depression, and other comorbid conditions, the key to proper management is a comprehensive evaluation, including sexual function, and an accurate differential diagnosis...
  28. ncbi Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder
    Mukund Gnanadesikan
    Department of Psychiatry, University of Arizona, Tuscon 85724, USA
    Bipolar Disord 5:203-16. 2003
    ....
  29. ncbi Metabolic effects of treatment with atypical antipsychotics
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA
    J Clin Psychiatry 65:1447-55. 2004
  30. ncbi Consultative intervention to improve outcomes of high utilizers in a public mental health system
    Terry Badger
    College of Nursing, The University of Arizona, Tucson, AZ, USA
    Perspect Psychiatr Care 40:53-60, 69. 2004
    ..To examine the effectiveness of an academic consultation on outcomes among consumers in a public mental health system and to compare outcomes between high-cost/high-utilizer and midcost consumers...
  31. ncbi Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial
    Patrick J Lustman
    Department of Veterans Affairs Medical Center, St Louis, MO, USA
    Arch Gen Psychiatry 63:521-9. 2006
    ..In patients with diabetes mellitus, depression is a prevalent and recurrent problem that adversely affects the medical prognosis...
  32. ncbi Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder
    Michael R Liebowitz
    New York State Psychiatric Institute, New York 10032, USA
    Arch Gen Psychiatry 62:190-8. 2005
    ..Evidence indicates that venlafaxine hydrochloride extended release (ER) effectively ameliorates anxiety symptoms...
  33. ncbi Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002
    Thomas Delate
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Psychiatr Serv 55:387-91. 2004
    ..The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002...
  34. pmc Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone
    Rachel Manber
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Consult Clin Psychol 76:459-67. 2008
    ..The authors conclude that combined antidepressant medications and psychotherapy result in faster full remission of chronic forms of major depressive disorder...
  35. doi Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study
    Marlene P Freeman
    Women s Mental Health Center, University of Texas Southwestern Medical Center, Dallas TX, USA
    J Affect Disord 110:142-8. 2008
    ..This study was designed to investigate the feasibility, safety, and efficacy of omega-3 fatty acids for perinatal depression in addition to supportive psychotherapy...
  36. ncbi The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
    Martin B Keller
    Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
    J Clin Psychiatry 68:1246-56. 2007
    ..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
  37. ncbi The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
    Martin B Keller
    Brown University, Providence, Rhode Island 02906, USA
    Biol Psychiatry 62:1371-9. 2007
    ..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
  38. ncbi The effectiveness of generic agents in psychopharmacologic treatment
    Richard Kumet
    Southern Arizona VA Healthcare System, Tuscon, AZ, USA
    Essent Psychopharmacol 6:104-11. 2005
    ..However, there can be important differences between the innovator drugs and generics, as well as among the generics themselves. More research needs to be done to establish true comparability...